Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by prophetoffactzon Dec 18, 2022 5:14pm
132 Views
Post# 35178642

RE:RE:RE:A 'Saltarelli' On Steroids?

RE:RE:RE:A 'Saltarelli' On Steroids?Thanks fuzzyjr.

I think some were way overcommited here to a single very high risk stock. They didn't manage risk properly in a portfolio context and they are now controlled by dissapointment, anger, and frusteration. They have lost focus on the emerging opportunity at hand and are lost in the past or focused on the personal failure. They aren't rolling with the punches with a clear mind. They don't fully appreciate what hit them in the worst biotech market in history. I've warned of the risks and pointed out 25% of biotech was trading below cash in recent months. From a once-in-a-century pandemic to Putin's war(largest in Europe in about 70 years) we've suffered multi-decade high inflation. Central banks have been slamming on the brakes and long-dated assets like biotech where the cashlow can be many, many years in the future have been slammed hard. Many biotech stocks will go under or undergo a significant reset with massive dilution. After COVID delays and in the worst biotech market in history BTI is trying to reset and create a stronger more resilient company. It is focusing on the future and trying to escape what has kept it back for a long time. The stock is still very high risk and hopefully there is more clarity with the webinar on Tuesdayand and in the near future with events. The market is still at risk as central bankers and the market try to resolve the ongoing inflation problem. We are at risk of a potential crash near term. This is a time of uncertainty.

Image
<< Previous
Bullboard Posts
Next >>